Author:
Neef Cees,Touw Daniel J.,Stolk Leo M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference76 articles.
1. EMEA. Note for guidance on general considerations for clinical trials. ICH Topic E8: general considerations for clinical trials. Step 5. CPMP/ICH/291/95 [online]. Available from URL: http://www.emea.europa.eu/pdfs/human/ich/029195en.pdf [Accessed 2008 Jul 8]
2. Kraiczi H, Jang T, Ludden T, et al. Randomized concentration-controlled trials: motivations, use, and limitations. Clin Pharmacol Ther 2003; 74 (3): 203–14
3. Kuypers DRJ, de Jonge H, Naesens M, et al. Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients. Clin Ther 2008; 30 (4): 673–83
4. Ohman D, Cherma MD, Norlander B, et al. Determination of serum reboxetine enantiomers in patients on chronic medication with racemic reboxetine. Ther Drug Monit 2003; 25 (2): 174–82
5. Ulrich S, Lauter J. Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression. Clin Pharmacokinet 2002; 41 (11): 853–76
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献